We don’t face multiple separate crises. The system itself is the crisis and must be overcome, replaced and transformed.

The creation of the African Medicines Agency with the objective of maintaining European standards for medicines in the continent may hamper the supply of regular and economical versions of medicines in areas where access is already skewed 

Moderna’s filing for patents in South Africa puts a question mark on its intentions of honoring the pledge that it will not enforce patents during the pandemic. Activists fear that this may jeopardize the WHO’s technology sharing hub

During the Covid-19 pandemic, Pfizer has used every opportunity to maximize its profits, even if this meant reduced access to life-saving medical products for most of the world. The same is about to happen in the case of Paxlovid, the company’s Covid-19 oral treatment

The deliberate policy of big pharma and rich countries to leave large populations in poorer countries unvaccinated could plunge the world into another downturn

Fatima Hassan from Health Justice International talks about the TRIPS waiver proposal, vaccine apartheid, and the WTO’s role in pandemic response and recovery

Today we look at the UK’s Health and Social Care Bill and it’s impact on the NHS, a US jury ruling holding pharmacies liable for the opioid crisis, and more

The European Union has been at the forefront of the opposition that rich countries have shown towards the TRIPS waiver proposal for COVID-19 medical products. However, the EU’s position in the international arena is not shared by the people of Europe, who wish to see vaccines accessible in the Global South

From October 9-13, activists organized actions to pressure the EU and various European countries to support the TRIPS waiver proposal, pointing out that people continue to die because governments do not want to stand up to Big Pharma

The COVID-19 pandemic has again exposed the true nature of capitalism with profit being the primary driver irrespective of the rising inequalities

The Bolivian government reached an agreement with Biolyse, a Canadian drug manufacturer, to produce additional doses of COVID-19 vaccines if a compulsory license is issued. However, their efforts have been blocked by the interest of patent-holders profiteering on the pandemic.

Despite attempts by the European Commission to stall discussion on the TRIPS waiver proposal for COVID-19 vaccines, the proposal has inched forward with support from the European Parliament and some parliaments of EU members states